acquisitions that accompanied the "Biotech revolution". We evaluate the impact of past innovative activity on firms' innovation … importance of small firms for the technological change in pharmaceuticals, and suggest that large firms may persist in using …

in essential sectors such as pharmaceuticals. At the outset, they shared some common features: a considerable period of …. However, over fifty years, India has had much more success in building indigenous capabilities in pharmaceuticals than Brazil … policy played a crucial role and the endogenous responses in the national system of innovation consisted of two parts. On the …

This paper examines the relationship bewteen cross-country differences in drug price regulation and the location of … less likely to locate new investments in countries with more stringent price regulation. …

External referencing (ER) imposes a price cap for pharmaceuticals based on prices of identical products in foreign …

Using a sample of 46 000 EU firms from the Community Innovation Survey, this paper analyses the drivers of innovation … adoption. In contrast to most empirical studies on innovation diffusion in which a specific technology is analyzed, this study … applied in a context of binary endogenous variable to explain the choices made by firms regarding innovation. Distinctions are …